What is the significance of the CT (Computed Tomography) collateral score in evaluating an adult patient with acute ischemic stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Collateral Score in Acute Ischemic Stroke

The CT collateral score is a critical prognostic marker that independently predicts functional outcomes, infarct progression, and mortality in acute ischemic stroke patients, with good collaterals (typically score >3 on multiphase CTA) correlating with smaller infarct volumes, better 90-day functional independence, and greater benefit from reperfusion therapy including thrombectomy. 1

What the Collateral Score Measures

The collateral score quantifies the extent and quality of alternative blood flow pathways that bypass an occluded vessel to supply ischemic brain tissue. 2 This assessment can be performed using:

  • Multiphase CT angiography (mCTA): Provides time-resolved depiction of collaterals through multiple phases, allowing semiquantitative grading with superior accuracy compared to single-phase techniques 2
  • Single-phase CTA: Less accurate and tends to underestimate collateral status compared to mCTA 3
  • CT perfusion (CTP): Can quantify collateral flow through parameters like maximum cerebral blood flow in collateral vessels 4
  • Digital subtraction angiography (DSA): Considered the gold standard but invasive 2, 5

Prognostic Significance for Clinical Outcomes

Good collateral circulation independently predicts favorable functional outcome at 90 days after thrombectomy, even after adjusting for baseline stroke severity and recanalization success. 1, 6

Specific Outcome Predictions:

  • Functional independence: Patients with good collaterals (mCTA score >3) have 84.8% sensitivity for achieving 90-day modified Rankin Scale (mRS) score of 0-2 3
  • Hemorrhagic transformation risk: Higher collateral scores significantly correlate with lower risk of symptomatic intracerebral hemorrhage (sICH) 6, 4
  • Infarct volume: Better collaterals correlate with smaller infarcts on CT and lower stroke scale scores 1
  • Treatment benefit: Patients with good collaterals on baseline mCTA are more likely to benefit from endovascular thrombectomy (EVT) 2

Optimal Scoring Thresholds

A multiphase CTA collateral score of >3 optimally identifies patients with target mismatch on CT perfusion and predicts good clinical outcome. 3 This threshold provides:

  • 78.4% sensitivity and 90.9% specificity for identifying target mismatch 3
  • 84.8% sensitivity and 69.4% specificity for predicting 90-day mRS score of 0-2 3

The diagnostic efficacy of mCTA collateral score (AUC 0.697-0.902) is comparable to CT perfusion target mismatch assessment. 6, 3

Advantages of Multiphase CTA Over Single-Phase

Multiphase CTA should be the preferred method for collateral assessment because it:

  • Predicts patient outcome better than single-phase CTA and CTP 2
  • Has good interrater reliability 2
  • Covers the whole brain 2
  • Is robust against patient motion 2
  • Requires no post-processing 2
  • Provides useful information about extracranial vessel anatomy and clot length for procedural planning 2

Single-phase CTA significantly underestimates collateral status compared to mCTA (p < 0.01). 3

Impact on Treatment Decisions

For Thrombectomy Eligibility:

Collateral status should be integrated into treatment decision-making, particularly for patients with low ASPECTS scores or extended time windows. 1 The American Heart Association recommends that:

  • Good collaterals predict benefit from reperfusion therapy even in patients with ASPECTS <6 1
  • Collateral assessment helps distinguish fast versus slow progressors 1
  • In posterior circulation strokes, a 6-point CTA collateral score correlates with good outcomes after thrombectomy 1

For Risk Stratification:

  • Patients with poor collaterals have higher risk of hemorrhagic transformation and poor functional outcome despite treatment 2
  • The collateral score has good application value in risk-benefit evaluation after mechanical thrombectomy 6

Critical Caveats and Pitfalls

Location-Dependent Effects:

Excellent collaterals do not guarantee good outcomes in all cases. 1 A proximal MCA occlusion may occlude lenticulostriate arteries supplying the basal ganglia and internal capsule—structures that cannot be collateralized from the cortex. 2, 1 Therefore, excellent transcortical collaterals might preserve cortex but permanent hemiplegia can still result from infarction of the internal capsule. 2, 1

Recanalization Dependency:

The benefit of collaterals depends on achieving successful recanalization—collaterals alone without reperfusion do not guarantee good outcomes. 1 This emphasizes that collateral assessment should guide but not replace the decision to pursue reperfusion therapy.

Technical Limitations:

  • Extracranial stenoses and poor cardiac output can lead to underestimation of collaterals on mCTA 2
  • Collaterals can fail over time, though late window patients still show diverse collateral grades 1
  • CTP is subject to technical failures in up to 30% of patients and lacks standardized quantification 2

Practical Implementation

Grading System:

The proposed grading system evaluates collateral function based on:

  • Extent of collateral filling to the ischemic territory 2
  • Time to collateral filling compared to the contralateral hemisphere 2
  • Slow collateral flow: filling >2 seconds slower than contralateral side 2
  • Rapid collateral flow: filling within 2 seconds of contralateral side 2

Reading Efficiency:

Automated assistance software (e-CTA) can improve collateral scoring accuracy from 58.6% to 67.5% (p = 0.003), reduce reading time from 103.4 to 59.7 seconds (p = 0.001), and increase inter-rater agreement (Krippendorff's alpha from 0.366 to 0.676). 7

Integration with Other Imaging Markers

Collateral assessment should complement, not replace, ASPECTS scoring and clinical evaluation. 8 While ASPECTS quantifies early ischemic changes, collateral scores provide dynamic information about tissue viability and perfusion status. 2 The combination of ASPECTS and collateral scoring provides more comprehensive risk stratification than either alone. 1, 8

DWI-MRI remains the gold standard for ischemic core assessment, but mCTA collateral scoring offers a faster, more practical alternative in the emergency setting. 2

References

Guideline

Prognostic Significance of Collateral Score on CT Angiography in Stroke Thrombectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Collateral score based on CT perfusion can predict the prognosis of patients with anterior circulation ischemic stroke after thrombectomy].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2017

Research

Automated CT angiography collateral scoring in anterior large vessel occlusion stroke: A multireader study.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2025

Guideline

Alberta Stroke Program Early CT Score (ASPECTS) Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.